Pharmacist-Led IV-to-Oral Conversion Yields LOS, Cost Benefits

By Gina ShawA pharmacist-led IV-to-oral conversion protocol significantly improved length of stay (LOS) and cost outcomes, particularly in higher-acuity populations such as diabetes and sepsis, reported investigators from Memorial Hermann Greater Heights Hospital, in Houston, at the newly combined Making a Difference in Infectious Diseases (MAD-ID) 2026 and Society of Infectious Diseases Pharmacists annual conference, in Orlando, Florida.figure { display:inline-block; margin:0.5em; border:thin s